Whether the detrimental effect on cardiac function caused by loss of KLF2 expression in mouse neutrophils translates to human heart failure pathophysiology is an open and relevant question, the answer to which could support a therapeutic strategy aimed at promoting KLF2 function in neutrophils in patients with cardiac hypertrophy and failure. The gene discussed is KLF2; the disease is heart failure.